Cannabis use among adults undergoing cancer treatment
- PMID: 37354093
- PMCID: PMC11070130
- DOI: 10.1002/cncr.34922
Cannabis use among adults undergoing cancer treatment
Abstract
Background: Little is known about the risks and benefits of cannabis use in the context of cancer care. This study characterized the prevalence, reasons for use, and perceived benefits of cannabis and compared symptoms and perceived risks between those who reported past 30-day cannabis use and those who did not.
Methods: Adults undergoing cancer treatment at a National Cancer Institute-designated cancer center completed measures of sociodemographic characteristics, cannabis use, use modalities, reasons for use, perceived harms/benefits of use, physical and psychological symptoms, and other substance/medication use. Analyses compared patients who used or did not use cannabis in the past 30 days.
Results: Participants (N = 267) were 58 years old on average, primarily female (70%), and predominantly White (88%). Over a quarter of respondents (26%) reported past 30-day cannabis use, and among those, 4.5% screened positive for cannabis use disorder. Participants who used cannabis most often used edibles (65%) or smoked cannabis (51%), and they were younger and more likely to be male, Black, and disabled, and to have lower income and Medicaid insurance than participants who did not use cannabis. Those who used cannabis reported more severe symptoms and perceived cannabis as less harmful than those who did not use cannabis. The most common medical reasons for cannabis use were pain, cancer, sleep problems, anxiety, nausea/vomiting, and poor appetite. Participants reported the greatest cannabis-related symptom relief from sleep problems, nausea/vomiting, headaches, pain, muscle spasms, and anxiety.
Conclusions: Patients with cancer who used cannabis perceived benefits for many symptoms, although they showed worse overall symptomatology.
Plain language summary: Among adults undergoing cancer treatment, 26% reported cannabis use in the past 30 days. Those who used cannabis were more likely to be male and disabled and to have lower income and Medicaid insurance than those who did not use cannabis. Participants most commonly reported using cannabis for pain, cancer, sleep, anxiety, and nausea/vomiting and reported the greatest perceived benefits for sleep, nausea/vomiting, headaches, pain, muscle spasms, and anxiety, yet participants who used cannabis also reported feeling worse physically and psychologically compared to those who did not use cannabis. Participants who used cannabis were more likely to report that cannabis was less risky to their health than alcohol, smoking, and opioids than those who did not use cannabis.
Keywords: cancer; cannabis; medical marijuana; palliative care; supportive care; symptom management.
© 2023 American Cancer Society.
Conflict of interest statement
CONFLICT OF INTEREST STATEMENT
Susanna V. Ulahannan has been a consultant for Eisai, AstraZeneca, and IGM Biosciences and has received grants from Regeneron, Bristol-Myers Squibb, Merck, Ciclomed, Atreca, Evelo Biosciences, Isofol, Incyte, Adlai Nortye, IGM Biosciences, AstraZeneca, TESARO, Erasca, Pfizer, Celgene, AbbVie, Tempest, Takeda, Exelexis, Revolution Medicines, G1 Therapeutics, KLUS Pharma, Macrogenics, GlaxoSmithKline, Vigeo Therapeutics, Synermore Biologics, OncoMed Pharmaceuticals, Boehringer Ingelheim, Tarveda Therapeutics, Mersana Therapeutics, and ArQule. The other authors declare no conflicts of interest.
Figures
Similar articles
-
Perceptions, prevalence, and patterns of cannabis use among cancer patients treated at 12 NCI-Designated Cancer Centers.J Natl Cancer Inst Monogr. 2024 Aug 15;2024(66):202-217. doi: 10.1093/jncimonographs/lgae029. J Natl Cancer Inst Monogr. 2024. PMID: 39108244 Free PMC article.
-
Characteristics of adults with a medical cannabis license, reasons for use, and perceptions of benefit following medical cannabis legalization in Oklahoma.Prev Med Rep. 2022 Mar 22;27:101777. doi: 10.1016/j.pmedr.2022.101777. eCollection 2022 Jun. Prev Med Rep. 2022. PMID: 35392181 Free PMC article.
-
Cannabis use among cancer patients and survivors in the United States: a systematic review.JNCI Cancer Spectr. 2024 Jan 4;8(1):pkae004. doi: 10.1093/jncics/pkae004. JNCI Cancer Spectr. 2024. PMID: 38291891 Free PMC article.
-
[Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].Epidemiol Prev. 2017 Sep-Dec;41(5-6):279-293. doi: 10.19191/EP17.5-6.AD01.069. Epidemiol Prev. 2017. PMID: 29119763 Review. Italian.
-
Should Oncologists Recommend Cannabis?Curr Treat Options Oncol. 2019 Jun 3;20(7):59. doi: 10.1007/s11864-019-0659-9. Curr Treat Options Oncol. 2019. PMID: 31161270 Review.
Cited by
-
Symptom trajectories over time by cannabis use status among patients undergoing cancer treatment.Sci Rep. 2024 Nov 16;14(1):28319. doi: 10.1038/s41598-024-78501-4. Sci Rep. 2024. PMID: 39550373 Free PMC article.
-
Experiences and Comfort of Young Cancer Patients Discussing Cannabis with Their Providers: Insights from a Survey at an NCI-Designated Cancer Center.J Cancer Educ. 2024 Sep 19. doi: 10.1007/s13187-024-02507-9. Online ahead of print. J Cancer Educ. 2024. PMID: 39294413
-
Perceptions, prevalence, and patterns of cannabis use among cancer patients treated at 12 NCI-Designated Cancer Centers.J Natl Cancer Inst Monogr. 2024 Aug 15;2024(66):202-217. doi: 10.1093/jncimonographs/lgae029. J Natl Cancer Inst Monogr. 2024. PMID: 39108244 Free PMC article.
-
Concurrent substance use among cancer patients with and without a history of cannabis use since cancer diagnosis at an NCI-Designated Cancer Center in Florida.J Natl Cancer Inst Monogr. 2024 Aug 15;2024(66):224-233. doi: 10.1093/jncimonographs/lgad036. J Natl Cancer Inst Monogr. 2024. PMID: 39108241
-
Cancer stage and consideration of cannabis use among adult cancer survivors in Southern California.J Natl Cancer Inst Monogr. 2024 Aug 15;2024(66):282-289. doi: 10.1093/jncimonographs/lgad028. J Natl Cancer Inst Monogr. 2024. PMID: 39108235
References
-
- State Medical Cannabis Laws. National Conference of State Legislatures. Accessed July 10, 2022. https://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
